Article Details

Zanubrutinib by BeiGene for Unspecified B-Cell Lymphomas: Likelihood of Approval

Retrieved on: 2024-12-30 18:25:09

Tags for this article:

Click the tags to see associated articles and topics

Zanubrutinib by BeiGene for Unspecified B-Cell Lymphomas: Likelihood of Approval. View article details on hiswai:

Excerpt

Zanubrutinib by BeiGene for Unspecified B-Cell Lymphomas: Likelihood of Approval ... cell lymphoma (MCL) who have received at least a previous therapy.

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up